Quest Diagnostics (DGX) Tops Q1 EPS by 25c, Raises FY EPS Guidance

Quest Diagnostics (NYSE: DGX) reported Q1 EPS of $3.22, $0.25 better than the analyst estimate of $2.97. Revenue for the quarter came in at $2.61 billion versus the consensus estimate of $2.63 billion.

GUIDANCE:

Quest Diagnostics sees FY2022 EPS of $9.00-$9.50, versus the consensus of $9.03.

For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• MSCI acquires First Street for $120M to expand climate risk data